Markets:

Overview

News

Currencies

International

Treasuries

Outlook Therapeutics, Inc. - Common Stock (NQ:OTLK)

0.1911 -0.0095 (-4.74%)

Streaming Delayed Price Updated: 12:10 PM EDT, Apr 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Outlook Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 24, 2021

Gainers Ocuphire Pharma (NASDAQ:OCUP) stock rose 78.73% to $6.22 during Wednesday's pre-market session. The market value of their outstanding shares is at $107.6...

Via Benzinga

28 Stocks Moving in Wednesday's Pre-Market Session ↗

November 24, 2021

Gainers Engine Gaming and Media, Inc. (NASDAQ: GAME) rose 51% to $4.80 in pre-market trading after the company reported Q4 2021 and FY21 revenue was higher year over year....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 24, 2021

We're starting the last day of this short holiday week with a dive into the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension ↗

November 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Puma Biotech Announces Receipt Of Patent Extension For Breast Cancer Drug By...

Via Benzinga

Topics Intellectual Property

JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th

November 04, 2021

- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast roundtable discussions with members of Management and Thought Leaders across participating...

From JTC Team, LLC

Via AccessWire

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage ↗

October 10, 2021

Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive stocks and into risky bets...

Via Talk Markets

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology ↗

October 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage ↗

October 10, 2021

Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive...

Via Benzinga

Outlook Therapeutics: Q3 Earnings Insights ↗

August 13, 2021

Shares of Outlook Therapeutics (NASDAQ:OTLK) moved higher by 2.8% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 133....

Via Benzinga

Why Outlook Therapeutics Stock Surged Today ↗

August 03, 2021

Investors are excited about the potential of the drugmaker's experimental wet AMD treatment.

Via The Motley Fool

HC Wainwright Raises Price Target On Outlook Therapeutics After Wet AMD Trial Data ↗

August 03, 2021

H.C. Wainwright raised the price target on Outlook Therapeutics Inc (NASDAQ:

Via Benzinga

75 Biggest Movers From Yesterday ↗

August 04, 2021

Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company announced that the it has received approval for a...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 03, 2021

Gainers Arcturus Therapeutics (NASDAQ:ARCT) stock moved upwards by 29.05% to $44.73 during Tuesday's regular session. As of 12:35 EST, Arcturus Therapeutics's...

Via Benzinga

OTLK Stock: The Huge Trial News Lifting Outlook Therapeutics ↗

August 03, 2021

OTLK stock is on the move today. The company is coming forth with promising data on its treatment of a damaging eye disease.

Via InvestorPlace

48 Stocks Moving In Tuesday's Mid-Day Session ↗

August 03, 2021

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 64.4% to $7.15 after a Form 4 filing from the company showed 10% shareholder Retail Ecommerce Ventures...

Via Benzinga

Mid-Morning Market Update: Markets Down; Alibaba Posts Downbeat Q1 Sales ↗

August 03, 2021

Following the market opening Tuesday, the Dow traded down 0.20% to 34,767.20 while the NASDAQ fell 0.58% to 14,596.07. The S&P also fell, dropping 0.26% to 4,375.68. The U.S....

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 03, 2021

Gainers Outlook Therapeutics (NASDAQ:OTLK) shares increased by 38.49% to $3.13 during Tuesday's pre-market session. The company's market cap stands at $543.3...

Via Benzinga

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

21 Stocks Moving in Tuesday's Pre-Market Session ↗

August 03, 2021

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares rose 46% to $6.35 in pre-market trading following Form 4 filing from the company’s 10% owner, Retail Ecommerce...

Via Benzinga

Outlook Therapeutics Stock Surges Positive ONS-5010 Data In Wet AMD Patients ↗

August 03, 2021

Outlook Therapeutics Inc (NASDAQ: OTLK) stock is trading higher in premarket session in reaction to positive top-line results from Phase 3 NORSE TWO trial...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 21, 2021

Gainers Alterity Therapeutics (NASDAQ:ATHE) shares rose 17.59% to $1.47 during Wednesday's regular session. As of 12:31 EST, this security is trading at a volume of 55...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.